Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
145.59
+9.26 (6.79%)
At close: Aug 21, 2026, 4:00 PM EDT
144.50
-1.09 (-0.75%)
Pre-market: Aug 24, 2026, 7:45 AM EDT
Twist Bioscience Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 431.8 | 376.57 | 312.97 | 245.11 | 203.57 | 132.33 | |
Revenue Growth | 19.19% | 20.32% | 27.69% | 20.41% | 53.83% | 46.87% |
Cost of Revenue | 207.41 | 185.57 | 179.63 | 155.38 | 119.33 | 80.62 |
Gross Profit | 224.39 | 191 | 133.35 | 89.73 | 84.24 | 51.71 |
Selling, General & Admin | 290.29 | 246.98 | 218.4 | 189.74 | 212.95 | 135.9 |
Research & Development | 71.86 | 80.29 | 90.85 | 106.89 | 120.31 | 69.07 |
Operating Expenses | 362.16 | 327.26 | 309.25 | 296.63 | 333.26 | 204.97 |
Operating Income | -137.77 | -136.26 | -175.9 | -206.9 | -249.02 | -153.26 |
Interest Expense | - | - | - | - | -0.08 | -0.37 |
Interest & Investment Income | 8.02 | 11.36 | 15.34 | 14.37 | 3.06 | 0.44 |
Other Non Operating Income (Expenses) | 1.11 | -0.9 | -2.68 | -0.67 | -1.09 | - |
EBT Excluding Unusual Items | -128.65 | -125.8 | -163.24 | -193.21 | -247.13 | -153.19 |
Merger & Restructuring Charges | - | - | - | -9.38 | - | - |
Gain (Loss) on Sale of Assets | - | 48.85 | - | - | 4.61 | - |
Asset Writedown | - | - | -44.93 | -6.79 | - | - |
Legal Settlements | -7.21 | - | - | - | - | - |
Other Unusual Items | - | - | - | 5.91 | 14.25 | -0.84 |
Pretax Income | -135.85 | -76.95 | -208.17 | -203.47 | -228.27 | -154.03 |
Income Tax Expense | 0.86 | 0.72 | 0.56 | 1.15 | -10.41 | -1.93 |
Net Income | -136.72 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 |
Net Income to Common | -136.72 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 61 | 60 | 58 | 57 | 54 | 48 |
Shares Outstanding (Diluted) | 61 | 60 | 58 | 57 | 54 | 48 |
Shares Change | 3.44% | 3.09% | 1.99% | 5.57% | 11.68% | 23.12% |
EPS (Basic) | -2.23 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
EPS (Diluted) | -2.23 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -93.12 | -75.63 | -69.17 | -170.25 | -226.24 | -139.31 |
Free Cash Flow Per Share | -1.52 | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 |
Gross Margin | 51.96% | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
Operating Margin | -31.91% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% |
Profit Margin | -31.66% | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
Free Cash Flow Margin | -21.57% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% |
EBITDA | -115.28 | -114.31 | -147.07 | -177.59 | -232.51 | -143.51 |
EBITDA Margin | -26.70% | -30.35% | -46.99% | -72.45% | -114.22% | -108.45% |
D&A For EBITDA | 22.49 | 21.95 | 28.83 | 29.31 | 16.51 | 9.75 |
EBIT | -137.77 | -136.26 | -175.9 | -206.9 | -249.02 | -153.26 |
EBIT Margin | -31.91% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% |
Advertising Expenses | - | 7 | 5.2 | 2.9 | 2.4 | 2.5 |